Abnormal platelet amyloid-β protein precursor (AβPP) metabolism in Alzheimer's disease: identification and characterization of a new AβPP isoform as potential biomarker.

Previous findings demonstrated an altered pattern of amyloid-β protein precursor (AβPP) expression in platelets of Alzheimer's disease (AD) patients compared with either healthy control subjects or patients with non-Alzheimer-type dementia. In an attempt to explore the diagnostic potential of platelet AβPP metabolism, we have generated monoclonal antibodies directed to the N-terminal part of AβPP. We have observed two different antibody recognition patterns of AβPP: one resembling previously described 130 kDa and 105 kDa species and a novel AβPP 115 kDa form. This form was significantly increased in platelets of the mild cognitive impairment and AD group as compared to control subjects. The abundance of AβPP 115 kDa species correlated with the previously described AβPP 130/105 kDa ratio as well as with Mini-Mental State Examination score. Despite the inability of these particular monoclonal antibodies to recognize native forms of AβPP, identification of a new AβPP isoform in platelets as a potential AD biomarker can provide an additional tool for the development of a reliable diagnostic test to detect preclinical stages of AD.

[1]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[2]  Christian Humpel,et al.  Identifying and validating biomarkers for Alzheimer's disease , 2011, Trends in biotechnology.

[3]  T. Aittokallio,et al.  An update on clinical proteomics in Alzheimer’s research , 2010, Journal of neurochemistry.

[4]  P. Scheltens,et al.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.

[5]  C. Hong,et al.  Correlation between platelet amyloid precursor protein isoform ratio and cognition in Alzheimer's disease. , 2007, Journal of Alzheimer's disease : JAD.

[6]  R. Rosenberg,et al.  Platelet amyloid precursor protein processing: A bio-marker for Alzheimer's disease , 2006, Journal of the Neurological Sciences.

[7]  C. Hong,et al.  Cholinesterase Inhibitor Affects the Amyloid Precursor Protein Isoforms in Patients with Alzheimer’s Disease , 2005, Dementia and Geriatric Cognitive Disorders.

[8]  C Caltagirone,et al.  Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease , 2004, Neurology.

[9]  C. Caltagirone,et al.  Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. , 2003, Archives of neurology.

[10]  M. Luca,et al.  High cholesterol affects platelet APP processing in controls and in AD patients , 2003, Neurobiology of Aging.

[11]  J. Growdon,et al.  Age but Not Diagnosis Is the Main Predictor of Plasma Amyloid β-Protein Levels , 2003 .

[12]  G. Vega,et al.  Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients , 2003, Neurology.

[13]  L. Rozzini,et al.  Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms , 2002, Neurological Sciences.

[14]  G. Forloni,et al.  Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway. , 2000, The Biochemical journal.

[15]  R. Tanzi,et al.  Alzheimer disease-related abnormalities of amyloid beta precursor protein isoforms in the platelet: the brain's delegate in the periphery? , 1998, Archives of neurology.

[16]  L. Honig,et al.  Altered amyloid protein processing in platelets of patients with Alzheimer disease. , 1997, Archives of neurology.

[17]  M. Luca,et al.  Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome. , 1996, Archives of neurology.

[18]  E. Oguni,et al.  Amyloid β protein in plasma from patients with sporadic Alzheimer's disease , 1996, Journal of the Neurological Sciences.

[19]  L. I. Hecker,et al.  Detection of distinct isoform patterns of the β-amyloid precursor protein in human platelets and lymphocytes , 1992, Neurobiology of Aging.

[20]  R. Martins,et al.  The amyloid precursor protein of Alzheimer's disease is released by human platelets. , 1990, The Journal of biological chemistry.

[21]  A. Schmaier,et al.  Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein. , 1990, Science.

[22]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[23]  D. Aarsland,et al.  A novel blood test for the early detection of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[24]  C. Caltagirone,et al.  Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. , 2002, Archives of neurology.